- Home
- METCB vs FULC Comparison
METCB vs FULC Comparison
Compare METCB & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- METCB
- FULC
- Stock Information
- Founded
- METCB 2015
- FULC 2015
- Country
- METCB United States
- FULC United States
- Employees
- METCB N/A
- FULC N/A
- Industry
- METCB Coal Mining
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- METCB Energy
- FULC Health Care
- Exchange
- METCB Nasdaq
- FULC Nasdaq
- Market Cap
- METCB 397.7M
- FULC 468.1M
- IPO Year
- METCB N/A
- FULC 2019
- Fundamental
- Price
- METCB $12.75
- FULC $11.57
- Analyst Decision
- METCB Buy
- FULC Strong Buy
- Analyst Count
- METCB 7
- FULC 7
- Target Price
- METCB $41.71
- FULC $12.71
- AVG Volume (30 Days)
- METCB 140.7K
- FULC 926.2K
- Earning Date
- METCB 10-27-2025
- FULC 10-29-2025
- Dividend Yield
- METCB 4.79%
- FULC N/A
- EPS Growth
- METCB N/A
- FULC N/A
- EPS
- METCB N/A
- FULC N/A
- Revenue
- METCB $579,503,000.00
- FULC N/A
- Revenue This Year
- METCB N/A
- FULC N/A
- Revenue Next Year
- METCB $20.94
- FULC N/A
- P/E Ratio
- METCB N/A
- FULC N/A
- Revenue Growth
- METCB N/A
- FULC 2752.05
- 52 Week Low
- METCB $5.94
- FULC $2.32
- 52 Week High
- METCB $22.11
- FULC $12.19
- Technical
- Relative Strength Index (RSI)
- METCB 38.03
- FULC 68.33
- Support Level
- METCB $11.60
- FULC $10.75
- Resistance Level
- METCB $17.22
- FULC $12.05
- Average True Range (ATR)
- METCB 1.18
- FULC 0.76
- MACD
- METCB -0.27
- FULC 0.35
- Stochastic Oscillator
- METCB 20.12
- FULC 87.20
About METCB Ramaco Resources Inc. Class B
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.